The heart in muscular dystrophy

Area of Science:

• Cardiology
• Neurology
• Pediatrics

Background:

• Muscular dystrophy (MD) is a group of genetic disorders characterized by progressive skeletal muscle weakness.
• Cardiac involvement is a common and serious complication of MD, significantly contributing to morbidity and mortality.
• Subclinical cardiac involvement is frequent, making early detection challenging.

Purpose of the Study:

• To emphasize the importance of vigilant cardiac monitoring in pediatric patients with MD.
• To highlight the need for early identification and management of cardiac complications.
• To discuss current and future therapeutic strategies for managing cardiac involvement in MD.

Main Methods:

• Review of clinical presentation and diagnostic approaches for cardiac involvement in MD.
• Discussion of noninvasive cardiac testing modalities.
• Analysis of current treatment strategies and their impact on disease outcomes.

Main Results:

• Cardiac involvement in MD patients can present with minimal or no overt symptoms.
• Thorough clinical evaluation, including interval history and physical examination, is crucial.
• Noninvasive cardiac testing aids in the early detection of subclinical cardiac dysfunction.

Conclusions:

• Healthcare professionals must maintain a high index of suspicion for cardiac involvement in all pediatric MD patients.
• Timely and appropriate cardiac evaluation and management can mitigate disease progression and improve survival.
• While genetic engineering offers future hope, current advancements in clinical care and supportive management significantly benefit affected children.